Cargando…

Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case

BACKGROUND: Metastatic biliary tract cancer (BTC) has poor prognosis. Recently, patients with metastatic BTC who respond well to systemic chemotherapy can be treated by radical resection or “conversion surgery.” CASE PRESENTATION: A 67-year-old male patient was diagnosed with intrahepatic cholangioc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunematsu, Masashi, Haruki, Koichiro, Sakamoto, Taro, Uwagawa, Tadashi, Shiba, Hiroaki, Yanaga, Katsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591504/ https://www.ncbi.nlm.nih.gov/pubmed/31236705 http://dx.doi.org/10.1186/s40792-019-0656-z

Ejemplares similares

Radical resection of a primary unresectable duodenal cancer after chemotherapy using S-1 and cisplatin: report of a case
por: Kanehira, Masaru, et al.
Publicado: (2017)

Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
por: Uwagawa, Tadashi, et al.
Publicado: (2022)

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
por: Saito, Nobuhiro, et al.
Publicado: (2018)

Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
por: Takayanagi, Ryosuke, et al.
Publicado: (2017)

Case: Authentic multimodal therapy and liver resection for an initially unresectable intrahepatic cholangiocarcinoma
por: Sakata, Koichiro, et al.
Publicado: (2018)

A Successfully Treated Case of Intrahepatic Cholangiocarcinoma with Exacerbation of Dermatomyositis
por: Yasuda, Jungo, et al.
Publicado: (2018)

Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
por: Taniai, Tomohiko, et al.
Publicado: (2018)

Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
por: Franssen, Stijn, et al.
Publicado: (2023)

Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma
por: Inoue, Tadahisa, et al.
Publicado: (2022)

Glycogen synthase kinase‐3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells
por: Haruki, Koichiro, et al.
Publicado: (2017)

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB
por: Shirai, Yoshihiro, et al.
Publicado: (2018)

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
por: Huh, Gunn, et al.
Publicado: (2020)

Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report
por: Kawai, Hironari, et al.
Publicado: (2017)

Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2021)

Successful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case report
por: Tsunematsu, Masashi, et al.
Publicado: (2017)

Subphrenic abscess due to Clostridium perfringens after hepatic resection for hepatocellular carcinoma following emphysematous cholecystitis: Report of a case
por: Hamura, Ryoga, et al.
Publicado: (2020)

The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy
por: Tsunematsu, Masashi, et al.
Publicado: (2022)

Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma
por: Ishii, Masatsugu, et al.
Publicado: (2022)

A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report
por: Haruki, Koichiro, et al.
Publicado: (2015)

Spontaneous biliary peritonitis with common bile duct stones: report of a case
por: Hamura, Ryoga, et al.
Publicado: (2016)

Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial
por: Chan, Stephen Lam, et al.
Publicado: (2022)

Unusual Images of Mass-Forming Intrahepatic Cholangiocarcinoma
por: Takakura, Kazuki, et al.
Publicado: (2013)

Usefulness of aspartate aminotransferase to platelet ratio index as a prognostic factor following hepatic resection for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2018)

Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma
por: Cho, Seulki, et al.
Publicado: (2017)

Obstructive Jaundice Due to Hilar Bile Duct Compression with Encasement of the Right Hepatic Artery
por: Ito, Ryusuke, et al.
Publicado: (2009)

Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study
por: Hu, Yubin, et al.
Publicado: (2020)

Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Paz-Fumagalli, Ricardo, et al.
Publicado: (2021)

Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling
por: Gruttadauria, Salvatore, et al.
Publicado: (2021)

Spontaneous Pathological Complete Regression of Hepatocellular Carcinoma
por: Taniai, Tomohiko, et al.
Publicado: (2018)

Pulmonary Embolism in a Donor of Living Donor Liver Transplantation
por: Onda, Shinji, et al.
Publicado: (2019)

Hepatic Epithelioid Hemangioendothelioma: Difficult Differential Diagnosis from Angiosarcoma
por: Taniai, Tomohiko, et al.
Publicado: (2020)

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
por: Zhang, Wei, et al.
Publicado: (2023)

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
por: Shimizu, Shosei, et al.
Publicado: (2019)

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
por: Seidensticker, Ricarda, et al.
Publicado: (2016)

Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Yousaf, Ali, et al.
Publicado: (2019)

Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma—Role of Interventional Radiology
por: Fabritius, Matthias P., et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review
por: Massani, Marco, et al.
Publicado: (2021)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
por: Suksawat, Manida, et al.
Publicado: (2022)

Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
por: Varamo, Chiara, et al.
Publicado: (2019)

Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
por: Tomooka, Fumimasa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ab331r7lfcp15r39mnjto7h1cn